AI-generated summary
This in vitro study examined dual-wavelength photobiomodulation (655 nm and 808 nm) applied to fibroblasts at three energy densities, using single or triple treatment protocols. The authors report that 1 J/cm2 concurrent application increased cell viability by 3%, intracellular reactive oxygen species by 20%, and wound closure by 89% compared with untreated cells. Because the work was conducted in cell culture rather than in people or animals, the findings may not translate directly to clinical use.
- Who or what was studied
- Fibroblasts (in vitro cell culture)
- Wavelengths
- 655, 808 nm
- Limits stated in the abstract
- The study was conducted in vitro on fibroblasts, so results may not apply to in vivo or clinical settings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm, 808 nm
- Energy density (fluence)
- 2 J/cm2, 1 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wavelength, Wound healing, Reactive oxygen species, Laser, Near-infrared, Angiogenesis, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.